Drug Database
Back to search

Poland· PL-100451593

Leflunomide Aurovitas

A leflunomide product containing leflunomidum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC L04AK01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLeflunomide AurovitasATCL04AK01REGISTER NO.PL-100451593PACKS LISTED13CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about leflunomidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Leflunomide is registered in 15 of 19 countries.

Countries holding a registration under ATC L04AK01 (leflunomide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search leflunomide products by name

Leflunomide · ATC L04AK01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of leflunomide costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.47 in United States to $2.13 in Italy — a ×4.5 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Leflunomide · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • IT Italy$2.13
  • CH Switzerland$1.48
  • US United States$0.47 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Leflunomidum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
L04AK01
ATC class
Leflunomide
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 13

  • gtin
    05909991498429
  • gtin
    05909991498436
  • gtin
    05909991498443
  • gtin
    05909991498450
  • gtin
    05909991498467
  • gtin
    05909991498474
  • gtin
    05909991498481
  • gtin
    05909991498498
  • gtin
    05909991498504
  • gtin
    05909991498511
  • gtin
    05909991498528
  • gtin
    05909991498535
  • gtin
    05909991498542

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

805 interactions on record for leflunomide.

Graded by severity as the source publishes them — 537 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check leflunomide against other medicinesHow interaction checks work

Leflunomide · interactions on record

805 records

  • 537 severe
  • 47 moderate
  • 7 minor
  • 214 info

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • Chenodeoxycholic acidA05AA01severe
  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Leflunomide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All leflunomide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Leflunomid Stada
  • Belgium · Leflunomid Sandoz, Leflunomide Ab
  • Bulgaria · Багеда
  • Cyprus · Arotan
  • Czechia · Leflon, Leflugen
  • Germany · Leflon, Leflunomid 1 A Pharma
  • Denmark · Leflunomid, Leflunomid "egis"
  • Estonia · Leflunomide Elvim
  • Spain · Lefluartil, Leflunomida Aurovitas
  • Finland · Leflunomide Orion, Leflunomide Stada
  • France · Leflunomide Arrow, Leflunomide Biogaran
  • United Kingdom (Northern Ireland) · Leflunomide Aspire Pharma, Leflunomide Milpharm
  • Greece · Lefid, Lefluonia
  • Hungary · Leflunomid Sandoz
  • Ireland · Leflunomide Aspire Pharma (Malta)
  • Iceland · Arava, Leflunomide Medac
  • Italy · Leflunomide Aurobindo, Leflunomide Mylan
  • Liechtenstein · Arava, Leflunomide Medac
  • Lithuania · Leflunomide Elvim, Leflunomide Sandoz
  • Latvia · Leflunomide Elvim, Leflunomide Sandoz
  • Malta · Leflunomide Normon
  • Netherlands · Leflunomide Aurobindo, Leflunomide Cf
  • Norway · Arava, Leflunomide Medac
  • Portugal · Leflunomida Farmoz, Leflunomida Generis
  • Romania · Leflon, Leflunomidă Arena
  • Sweden · Leflunomid Bluefish

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/94eea9e8-af7a-46bd-a44d-9ee7d80fe68a
GET /v1/drugs/94eea9e8-af7a-46bd-a44d-9ee7d80fe68a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909991498429 ¦ Rpz ¦ 147169\n10 tabl.\n05909991498436 ¦ Rpz ¦ 147170\n15 tabl.\n05909991498443 ¦ Rpz ¦ 147171\n30 tabl. w blistrze\n05909991498450 ¦ Rpz ¦ 147172\n90 tabl.\n05909991498467 ¦ Rpz ¦ 147173\n60 tabl.\n05909991498474 ¦ Rpz ¦ 147174\n100 tabl.\n05909991498481 ¦ Rpz ¦ 147175\n10 tabl.\n05909991498498 ¦ Rpz ¦ 147176\n15 tabl.\n05909991498504 ¦ Rpz ¦ 147177\n30 tabl. w blistrze\n05909991498511 ¦ Rpz ¦ 147178\n60 tabl.\n05909991498528 ¦ Rpz ¦ 147179\n90 tabl.\n05909991498535 ¦ Rpz ¦ 147180\n100 tabl.\n05909991498542 ¦ Rpz ¦ 147181\n30 tabl. w butelce",
  "substance": "Leflunomidum 20 mg",
  "common_name": "Leflunomidum",
  "pl_product_id": "100451593",
  "pozwolenie_nr": "27407",
  "auth_procedure": "DCP",
  "authorisation_validity": "2027-10-19"
}
API referenceMCP serverPlans

See everything about leflunomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console